Renal immune‐related adverse events of immune checkpoint inhibitor-Reference-Cited by-同舟云学术

Renal immune‐related adverse events of immune checkpoint inhibitor

Published:2020-06-23 Issue:6 Volume:16 Page:305-311
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Hu Rongrong¹,Chen Minjiang²,Xu Yan²,Wang Mengzhao²,Zheng Ke¹^ORCID,Li Xuemei¹

Affiliation:

1. Department of Nephrology Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

2. Department of Respiratory and Critical Care Medicine Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing China

Funder

CAMS Innovation Fund for Medical Science

“13th Five-Year” National Science and Technology Major Project for New Drugs

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13387

Reference30 articles.

1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893;Coley WB;Clin Orthop Relat Res,1991

2. Acute Kidney Injury in Patients with Cancer

3. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

4. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

5. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA sequencing analysis of peripheral blood mononuclear cells in PD-1-induced renal toxicity in patients with lung cancer;BMC Nephrology;2024-09-14

2. Adverse Effects of Immune-Checkpoint Inhibitors: A Comprehensive Imaging-Oriented Review;Current Oncology;2023-05-03

3. Clinical outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center;Immunotherapy;2023-04

4. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors;Anti-Cancer Drugs;2022-12-19

5. Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system;International Journal of Clinical Pharmacy;2022-04-21